Form 4: NeuroOne Director Sells Shares for Tax Obligations

NeuroOne Medical Technologies' Business Development Director, Mark Christianson, disposed of 253 common shares to cover tax withholding obligations.

Summary

• Mark Christianson, Business Development Director at NeuroOne Medical Technologies Corp (NMTC), reported a transaction.
• On December 31, 2025, Christianson disposed of 253 shares of common stock.
• The disposition was made at a price of $0.758 per share.
• This transaction was coded as 'F', indicating a disposition to the issuer to satisfy tax withholding obligations.
• Following this transaction, Christianson beneficially owns 230,732 shares of common stock.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction for tax withholding purposes, not indicative of positive or negative sentiment towards the company's performance or future prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Minimal direct impact on shareholders as it's a small, routine transaction for tax purposes by an insider.

Key Dates

Recommendation

The filing details a routine insider transaction where shares were disposed of to satisfy tax withholding obligations. This type of transaction is common and typically does not reflect a change in the insider's confidence in the company or its future prospects. Therefore, it does not provide a basis for altering an existing investment recommendation.

Keywords

NeuroOne Medical Technologies, NMTC, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Mark Christianson, Business Development Director